Emerging roles of autophagy in the stressed kidney allograft

Seminars in Nephrology

Volumn 34, Issue 1, 2014, Pages 34-41

  Pallet, Nicolas ^a,b  

^a INSERM   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Autophagy; Cell stress; Inflammation; Kidney; Transplantation

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; AUTOPHAGY; CELL COMMUNICATION; COLD ISCHEMIA; CRYOPRESERVATION; DIABETES MELLITUS; DRUG MECHANISM; DYSLIPIDEMIA; EDEMA; END STAGE RENAL DISEASE; GRAFT REJECTION; HUMAN; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MOUTH ULCER; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RASH; RENAL GRAFT DYSFUNCTION; REPERFUSION INJURY; REVIEW;

AUTOPHAGY; CELL STRESS; INFLAMMATION; KIDNEY; TRANSPLANTATION;

ADAPTIVE IMMUNITY; ALLOGRAFTS; ANIMALS; AUTOPHAGY; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; REPERFUSION INJURY; STRESS, PHYSIOLOGICAL;

EID: 84893381040     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2013.11.006     Document Type: Review

References (75)

1. Racusen L.C., Regele H. The pathology of chronic allograft dysfunction. Kidney Int Suppl 2010, 119:S27-S32.
2. Zeisberg M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 2010, 21:1819-1834.
3. Nankivell B.J., Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81:643-654.
4. Perico N., Cattaneo D., Sayegh M., Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004, 364:1814-1827.
5. Bonventre J., Zuk A. Ischemic acute renal failure: an inflammatory disease?. Kidney Int 2004, 66:480-485.
6. Anders H. Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 2010, 21:1270-1274.
7. Anders H., Schlondorff D. Innate immune receptors and autophagy: implications for autoimmune kidney injury. Kidney Int 2010, 78:29-37.
8. Zhang K., Kaufman R.J. From endoplasmic-reticulum stress to the inflammatory response. Nature 2008, 454:455-462.
9. Lee D., Hung M. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle 2007, 15:3011-3014.
10. Nizet V., Johnson R. Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 2009, 9:609-617.
11. Sumpter R., Levine B. Autophagy and innate immunity: triggering, targeting and tuning. Semin Cell Dev Biol 2010, 21:699-711.
12. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol Cell 2011, 40:280-293.
13. Levine B., Mizushima N., Virgin H.W. Autophagy in immunity and inflammation. Nature 2011, 469:323-335.
14. Fine L.G., Norman J.T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 2008, 74:867-872.
15. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
16. Bonventre J. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 2007, 156:213-219.
17. Eddy A.A. Molecular basis of renal fibrosis. Pediatr Nephrol 2000, 15:290-301.
18. Eddy A.A., Neilson E.G. Chronic kidney disease progression. J Am Soc Nephrol 2006, 17:2964-2966.
19. Perico N., Cattaneo D., Sayegh M.H., Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004, 364:1814-1827.
20. Turkmen K., Martin J., Akcay A., Nguyen Q., Ravichandran K., Faubel S., et al. Apoptosis and autophagy in cold preservation ischemia. Transplantation 2011, 91:1192-1197.
21. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
22. Zhu C., Wang X., Xu F., Bahr B.A., Shibata M., Uchiyama Y., et al. The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 2005, 12:162-176.
23. Chien C.T., Shyue S.K., Lai M.K. Bcl-xL augmentation potentially reduces ischemia/reperfusion induced proximal and distal tubular apoptosis and autophagy. Transplantation 2007, 84:1183-1190.
24. Suzuki C., Isaka Y., Takabatake Y., Tanaka H., Koike M., Shibata M., et al. Participation of autophagy in renal ischemia/reperfusion injury. Biochem Biophys Res Commun 2008, 368:100-106.
25. Isaka Y., Suzuki C., Abe T., Okumi M., Ichimaru N., Imamura R., et al. Bcl-2 protects tubular epithelial cells from ischemia/reperfusion injury by dual mechanisms. Transplant Proc 2009, 41:52-54.
26. Jiang M., Liu K., Luo J., Dong Z. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol 2010, 176:1181-1192.
27. Kimura T., Takabatake Y., Takahashi A., Kaimori J.Y., Matsui I., Namba T., et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol 2012, 22:902-913.
28. Liu S., Hartleben B., Kretz O., Wiech T., Igarashi P., Mizushima N., et al. Autophagy plays a critical role in kidney tubule maintenance, aging and ischemia-reperfusion injury. Autophagy 2012, 8:826-837.
29. Jiang M., Wei Q., Dong G., Komatsu M., Su Y., Dong Z. Autophagy in proximal tubules protects against acute kidney injury. Kidney Int 2012, 82:1271-1283.
30. Lieberthal W., Fuhro R., Andry C.C., Rennke H., Abernathy V.E., Koh J.S., et al. Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Renal Physiol 2001, 281:F693-F706.
31. Nakagawa S., Nishihara K., Inui K., Masuda S. Involvement of autophagy in the pharmacological effects of the mTOR inhibitor everolimus in acute kidney injury. Eur J Pharmacol 2012, 696:143-154.
32. Pallet N., Thervet E., Le Corre D., Knebelmann B., Nusbaum P., Tomkiewicz C., et al. Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. Kidney Int 2005, 67:2422-2433.
33. Shoji-Kawata S., Sumpter R., Leveno M., Campbell G.R., Zou Z., Kinch L., et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature 2013, 494:201-206.
34. Duran J.M., Anjard C., Stefan C., Loomis W.F., Malhotra V. Unconventional secretion of Acb1 is mediated by autophagosomes. J Cell Biol 2011, 188:527-536.
35. Manjithaya R., Anjard C., Loomis W.F., Subramani S. Unconventional secretion of Pichia pastoris Acb1 is dependent on GRASP protein, peroxisomal functions, and autophagosome formation. J Cell Biol 2010, 188:537-546.
36. Dupont N., Jiang S., Pilli M., Ornatowski W., Bhattacharya D., Deretic V. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1beta. EMBO J 2011, 30:4701-4711.
37. Sirois I., Groleau J., Pallet N., Brassard N., Hamelin K., Lonono I., et al. Caspase activation regulates the extracellular export of autophagic vacuoles. Autophagy 2012, 8:927-937.
38. Pallet N., Sirois I., Bell C., Hanafi L.A., Hamelin K., Dieude M., et al. A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells. Proteomics 2013, 13:1108-1120.
39. El-Zoghby Z.M., Stegall M.D., Lager D.J., Kremers W.K., Amer H., Gloor J.M., et al. Identifying specific causes of kidney allograft loss. Am J Transplant 2009, 9:527-535.
40. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., Chapman J.R. The natural history of chronic allograft nephropathy. N Engl J Med 2003, 349:2326-2333.
41. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Chapman J.R., Allen R.D. Calcineurin inhibitor nephrotoxicity: longitudinal assessment by protocol histology. Transplantation 2004, 78:557-565.
42. Campistol J.M., Sacks S.H. Mechanisms of nephrotoxicity. Transplantation 2000, 69:SS5-10.
43. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 2004, 15:1-12.
44. Zeisberg M., Strutz F., Muller G.A. Renal fibrosis: an update. Curr Opin Nephrol Hypertens 2001, 10:315-320.
45. Pallet N., Bouvier N., Bendjallabah A., Rabant M., Flinois J.P., Hertig A., et al. Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death. Am J Transplant 2008, 8:2283-2296.
46. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 2000, 101:451-454.
47. Yu L., Lenardo M.J., Baehrecke E.H. Autophagy and caspases: a new cell death program. Cell Cycle 2004, 3:1124-1126.
48. Zhang K., Kaufman R.J. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 2004, 279:25935-25938.
49. Hoyer-Hansen M., Jaattela M. Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. Cell Death Differ 2007, 14:1576-1582.
50. Moretti L., Cha Y.I., Niermann K.J., Lu B. Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress?. Cell Cycle 2007, 6:793-798.
51. Ding W.X., Ni H.M., Gao W., Yoshimori T., Stolz D.B., Ron D., et al. Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability. Am J Pathol 2007, 171:513-524.
52. Lim S.W., Hyoung B.J., Piao S.G., Doh K.C., Chung B.H., Yang C.W. Chronic cyclosporine nephropathy is characterized by excessive autophagosome formation and decreased autophagic clearance. Transplantation 2012, 94:218-225.
53. Pallet N., Legendre C. Adverse events associated with mTOR inhibitors. Expert Opin Drug Saf 2012, 12:177-186.
54. Godel M., Hartleben B., Herbach N., Liu S., Zschiedrich S., Lu S., et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J Clin Invest 2011, 121:2197-2209.
55. Hartleben B., Godel M., Meyer-Schwesinger C., Liu S., Ulrich T., Kobler S., et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010, 120:1084-1096.
56. Powell J.D., Delgoffe G.M. The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity 2010, 33:301-311.
57. Saemann M.D., Haidinger M., Hecking M., Horl W.H., Weichhart T. The multifunctional role of mTOR in innate immunity: implications for transplant immunity. Am J Transplant 2009, 9:2655-2661.
58. Tanemura M., Ohmura Y., Deguchi T., Machida T., Tsukamoto R., Wada H., et al. Rapamycin causes upregulation of autophagy and impairs islets function both in vitro and in vivo. Am J Transplant 2012, 12:102-114.
59. Beljanski V., Knaak C., Smith C.D. A novel sphingosine kinase inhibitor induces autophagy in tumor cells. J Pharmacol Exp Ther 2010, 333:454-464.
60. Chaigne-Delalande B., Guidicelli G., Couzi L., Merville P., Mahfouf W., Bouchet S., et al. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal. J Immunol 2008, 181:7630-7638.
61. Famulski K.S., Einecke G., Sis B., Mengel M., Hidalgo L.G., Kaplan B., et al. Defining the canonical form of T-cell-mediated rejection in human kidney transplants. Am J Transplant 2010, 10:810-820.
62. Mengel M., Chang J., Kayser D., Gwinner W., Schwarz A., Einecke G., et al. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant 2011, 11:708-718.
63. Hidalgo L.G., Halloran P.F. Role of IFN-gamma in allograft rejection. Crit Rev Immunol 2002, 22:317-349.
64. Shi C.S., Kehrl JH TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal 2010, 3. 2010;3:ra42.
65. Tu S.P., Quante M., Bhagat G., Takaishi S., Cui G., Yang X.D., et al. IFN-gamma inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosis. Cancer Res 2011, 71:4247-4259.
66. Singh S.B., Davis A.S., Taylor G.A., Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006, 313:1438-1441.
67. Kim B.H., Shenoy A.R., Kumar P., Das R., Tiwari S., MacMicking J.D. A family of IFN-gamma-inducible 65-kD GTPases protects against bacterial infection. Science 2011, 332:717-721.
68. Fougeray S., Mami I., Bertho G., Beaune P., Thervet E., Pallet N. Tryptophan depletion and the kinase GCN2 mediate IFN-gamma-induced autophagy. J Immunol 2012, 189:2954-2964.
69. Nakahira K., Haspel J., Rathinam V., Lee S., Dolinay T., Lam H., et al. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 2011, 1:222-230.
70. Shi C.S., Shenderov K., Huang N.N., Kabat J., Abu-Asab M., Fitzgerald K.A., et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 2012, 13:255-263.
71. Michaud M., Martins I., Sukkurwala A.Q., Adjemian S., Ma Y., Pellegatti P., et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011, 334:1573-1577.
72. Caron E., Vincent K., Fortier M.H., Laverdure J.P., Bramoulle A., Hardy M.P., et al. The MHC I immunopeptidome conveys to the cell surface an integrative view of cellular regulation. Mol Syst Biol 2011, 7:533.
73. Hernandez-Gea V., Ghiassi-Nejad Z., Rozenfeld R., Gordon R., Fiel M.I., Yue Z., et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 2012, 142:938-946.
74. Martinet W., Schrijvers D.M., Timmermans J.P., Bult H., De Meyer G.R. Immunohistochemical analysis of macroautophagy: recommendations and limitations. Autophagy 2013, 9:386-402.
75. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.